CLINICAL_TRIALS
trial_result
· 2021-06-03
Clinical Trial Update: The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]
Summary
Phase 2 trial update evaluating SPD465 for adults with ADHD has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 2 | Status: COMPLETED